
0.00
- With a market cap of N/A.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Quarterly Results & Audited Results |
| 14 08 2021 | Quarterly Results |
| 27 08 2021 | Increase in Authorised Capital & A.G.M. Inter alia to transact the following items: 1. To Fix the Date & Time of 32nd Annual General Meeting (AGM) of the Company. 2. To Fix the Dates of Book Closure 3. To Approve the Notice, Boards Report and other reports 4. To Consider the increase of authorised Capital of the company 5. To discuss any other items with the permission of Chairman. |
| 21 10 2021 | Quarterly Results |
| 12 01 2022 | Quarterly Results & Preferential Issue of shares & Issue Of Warrants |
| 04 02 2022 | Increase in Authorised Capital & Bonus issue |
| 20 05 2022 | Audited Results |
| 12 07 2022 | Quarterly Results |
| 09 11 2022 | Quarterly Results |
| 27 01 2023 | Preferential Issue of shares & Issue Of Warrants Inter-alia, to consider: 1. Proposal for issuance of equity shares/warrants by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of preferential allotment, as required |
| 08 02 2023 | Quarterly Results |
| 15 05 2023 | Audited Results |
| 14 07 2023 | Quarterly Results |
| 13 11 2023 | Quarterly Results |
| 19 01 2024 | Quarterly Results |
| 24 01 2024 | Quarterly Results |
| 06 11 2024 | Quarterly Results |
| 21 11 2024 | Employees Stock Option Plan |
| 27 01 2025 | Quarterly Results & Preferential Issue of shares |
| 28 05 2025 | Preferential Issue of shares & Inter alia, t the Board of Directors shall also consider the following additional agenda item in the Board meeting scheduled to be held on Wednesday, May 28, 2025:- 1. Proposal for raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, preferential allotment, private placement, or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, and other applicable law, to such investors, as may be permitted to invest in such issuance of securities, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of raising of funds, as required. |
| 14 08 2025 | Quarterly Results |
| 22 08 2025 | inter-alia to transact the following business. 1. Restructuring the SaaS business into a 100% subsidiary via slump sale to create a focused SaaS entity, thus unlocking long-term shareholder value 2. Divesting a portion of the SaaS business via private investment, strategic partnerships, or IPO, and utilising proceeds to reduce debt at the consolidated level as well as invest in oncology healthcare vertical to expand the Virinchi hospital chain. |
| 15 10 2025 | Preferential Issue of shares & Inter alia, to consider the following agenda item: 1. Proposal for raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, preferential allotment, private placement, or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, and other applicable law, to such investors, as may be permitted to invest in such issuance of securities, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal for raising of funds, as required. |
| 13 11 2025 | Quarterly Results |
| 04 02 2026 | Quarterly Results |
